Rayan Kassirr | Young Scientist Award | Cancer Research

Published on by Academic Achievements

Young Scientist Award

Rayan Kassirr
Lebanese University

Rayan Kassirr is a researcher affiliated with Lebanese University, Lebanon, whose academic profile is associated with cancer research. With documented scholarly activity including three documents, 31 citations, and an h-index of 3, the profile demonstrates an emerging contribution to research in the field. The recognition context is the International Academic Achievements & Awards event.

Rayan Kassirr
Affiliation Lebanese University
Country Lebanon
Documents 3
Subject Area Cancer Research
Event International Academic Achievements & Awards
ORCID 0009-0009-0605-4177

Abstract

Rayan Kassirr is an emerging academic researcher at Lebanese University, Lebanon, working within the broad field of cancer research. The available scholarly record identifies three documents, 31 citations, and an h-index of 3. These indicators provide a quantitative snapshot of research activity and citation visibility. The Young Scientist Award recognizes developing researchers whose scholarly work demonstrates potential, academic engagement, and relevance to their research discipline.

Keywords

Cancer research; Young Scientist Award; Lebanese University; biomedical research; scholarly publications; research impact; academic achievement.

Introduction

Cancer research encompasses multidisciplinary investigations addressing cancer biology, prevention, diagnosis, treatment, and patient outcomes. The continued development of researchers in this field is important because scientific progress depends on sustained investigation and evidence-based scholarship. Rayan Kassirr’s academic profile is positioned within this research environment, with the reported publication and citation record providing evidence of scholarly participation.

Research Profile

The researcher is affiliated with Lebanese University in Lebanon and is associated with cancer research. The reported Scopus metrics comprise three documents, 31 citations, and an h-index of 3. The research profile should be interpreted as a current bibliometric snapshot rather than a complete assessment of academic quality, since citation indicators vary by discipline, publication age, database coverage, and research specialty.

Research Contributions

Within cancer research, scholarly contributions may involve experimental studies, clinical investigations, molecular analysis, computational approaches, or interdisciplinary biomedical research. The documented publication record indicates active participation in scholarly communication. Individual contributions should be evaluated through the underlying publications, methodologies, findings, authorship roles, and independent academic assessment rather than bibliometric measures alone.

Publications

The available profile records three scholarly documents. Detailed publication titles, journals, publication years, and DOI identifiers were not supplied in the source information for this article. Accordingly, no specific publication or DOI has been attributed to the researcher without verifiable bibliographic information. Citation data reported for the profile are recorded as 31 citations.

Research Impact

The reported 31 citations and h-index of 3 indicate that the researcher’s publications have received scholarly references within the indexed literature. Citation indicators can provide one perspective on research visibility, while broader impact may also include methodological contributions, collaboration, educational value, clinical relevance, data generation, and influence on subsequent research. [1]

Award Suitability

The Young Scientist Award is suitable for consideration of an emerging researcher whose academic record demonstrates research engagement and developing scholarly influence. Rayan Kassirr’s affiliation, cancer research specialization, three documented publications, 31 citations, and h-index of 3 provide relevant evidence for an academic recognition profile. Final award decisions should additionally consider originality, methodological quality, publication quality, research significance, ethical standards, and the applicant’s overall contribution.

Conclusion

Rayan Kassirr represents an emerging research profile associated with Lebanese University and cancer research in Lebanon. The available bibliometric indicators document three scholarly documents, 31 citations, and an h-index of 3. These indicators, together with the researcher’s disciplinary focus, provide a foundation for consideration within the Young Scientist Award category at the International Academic Achievements & Awards event.

References

  1. ORCID. (n.d.). ORCID record for Rayan Kassirr.https://orcid.org/0009-0009-0605-4177
  2. International Academic Achievements & Awards. (n.d.). Academic awards information.https://awardsandrecognitions.com/

Noura Atef Abdel Sattar Ebrahim | Oncologic Pathology | Best Researcher Award

Published on by Academic Achievements

Dr. Noura Atef Abdel Sattar Ebrahim | Oncologic Pathology | Best Researcher Award

Dr. Noura Atef Abdel Sattar Ebrahim| Oncologic Pathology |Associate Professor  at Cairo University, Egypt

Dr. Noura Atef Abdel Sattar Ebrahim is an Assistant Professor of Oncologic Pathology at the National Cancer Institute, Cairo University. She specializes in the molecular pathology of cancer, particularly ovarian and breast carcinoma, with a focus on understanding tumor markers and their clinical implications. Dr. Ebrahim completed her Ph.D. in Oncologic Pathology in 2024, focusing on the expression of SOX10 and Beta-Catenin in ovarian serous carcinoma. She also holds a Master’s degree in Pathology from Cairo University. Throughout her career, Dr. Ebrahim has received several awards, including the “Best Abstract Award” at the Baheya Breast Cancer Conference and “Best Doctoral Thesis” at the National Cancer Institute. She actively contributes to research in cancer biomarkers, molecular subtypes, and clinicopathological analysis. With her extensive teaching experience and active involvement in scientific publishing, Dr. Ebrahim has become a respected figure in the oncology research community.

Professional Profile

Orcid

Education

Dr. Noura Atef Abdel Sattar Ebrahim earned her Doctorate in Oncologic Pathology from the National Cancer Institute, Cairo University, in 2024, where she investigated the expression of SOX10 and Beta-Catenin in ovarian serous carcinoma. Her research focused on understanding the role of these proteins in the progression of cancer. In 2018, she obtained her Master’s in Pathology from Cairo University, with a thesis that examined breast carcinoma molecular subtypes and their correlation with axillary lymph node metastasis and chemotherapy response. Prior to her graduate studies, Dr. Ebrahim earned her Bachelor of Medicine and Surgery from Kasr Al-Ainy School of Medicine, Cairo University, in 2011, graduating with excellent grades. Throughout her academic journey, Dr. Ebrahim demonstrated excellence in clinical pathology, molecular diagnostics, and research methodology, building a solid foundation in oncologic pathology. Her academic achievements have propelled her into a successful research and teaching career.

Experience

Dr. Noura Atef Abdel Sattar Ebrahim has significant academic and clinical experience in oncology  pathology. She is currently an Assistant Professor at the National Cancer Institute, Cairo University, where she has been teaching and conducting research since 2024. Prior to this, Dr. Ebrahim was a Lecturer at the same institution from 2019 to 2024, where she was actively involved in teaching undergraduate and doctoral students in oncology and pathology. She began her career as a Demonstrator at the National Cancer Institute from 2014 to 2019, focusing on cancer research and clinical pathology training. Before her work at the National Cancer Institute, Dr. Ebrahim completed her clinical training as a House Officer and Resident in Internal Medicine at Kasr Al-Ainy, Cairo University. She is also involved in scientific review activities for journals such as Biomedical Materials and Devices and World Journal of Hepatology, demonstrating her expertise and commitment to advancing oncologic pathology.

Research Interests

Dr. Noura Atef Abdel Sattar Ebrahim’s research focuses on the molecular mechanisms underlying cancer, specifically ovarian and breast carcinomas. Her work emphasizes the role of tumor markers such as SOX10 and Beta-Catenin, investigating their expression patterns and their clinical implications in cancer diagnosis and prognosis. Dr. Ebrahim’s doctoral thesis on the expression of SOX10 and Beta-Catenin in ovarian serous carcinoma aims to provide insights into the molecular pathways driving ovarian cancer progression. Additionally, her earlier research on breast carcinoma molecular subtypes and their correlation with lymph node metastases and chemotherapy response has contributed to personalized cancer treatment strategies. She is also involved in the study of immunohi stochemical markers such as Cyclin D1 and E-Cadherin in various cancers, including laryngeal squamous cell carcinoma. Dr. Ebrahim’s focus on integrating molecular biology with clinical pathology aims to improve cancer detection, treatment, and patient outcomes through precision medicine.

Awards

Dr. Noura Atef Abdel Sattar Ebrahim has received several prestigious awards for her research and academic contributions. In 2021, she won the Best Abstract Award at the Baheya Breast Cancer Conference for her research on breast carcinoma molecular subtypes. This recognition highlighted the significant impact of her findings on breast cancer diagnostics and treatment. In 2024, Dr. Ebrahim was honored with the Best Doctoral Thesis Award at the National Cancer Institute, Cairo University, for her outstanding doctoral work on the expression of SOX10 and Beta-Catenin in ovarian serous carcinoma. These awards reflect her dedication to advancing oncology research and her contributions to the scientific community. Additionally, her work continues to be recognized by peers through oral and poster presentations at international conferences, such as the Bridging Gaps in Oncology and Baheya Breast Cancer Conferences, showcasing her leadership in the field of oncologic pathology.

Publications

Decoding β-catenin expression patterns in ovarian serous carcinoma with clinicopathological implications: insights from National Cancer Institute

Breast Carcinoma Molecular Subtypes: Correlation with Axillary Lymph Node Metastases and Post Neoadjuvant Chemotherapy Response

Ovarian Cancer Predictive Markers: Current and Future Prospective
Breast Carcinoma Molecular Subtypes: Correlation with Axillary Lymph Node Metastases and Post Neoadjuvant Chemotherapy Response

Assessment of Immunohistochemical Expression of Cyclin D1 and E-Cadherin in Laryngeal Squamous Cell Carcinoma

Doctorate of Oncologic Pathology – National Cancer Institute – Cairo University Thesis Entitled “Expression of SOX10 & Beta-Catenin in Ovarian Serous Carcinoma”

Master of Pathology – Kasr Al-Ainy School of Medicine – Cairo University Thesis Entitled “Breast Carcinoma Molecular Subtypes: Correlation with Axillary Lymph Node Metastases and Post Neoadjuvant Chemotherapy Response”

Natural Polymers in Micro- and Nanoencapsulation for Therapeutic and Diagnostic Applications: Part I: Lipids and Fabrication Techniques

Natural Polymers in Micro- and Nanoencapsulation for Therapeutic and Diagnostic Applications: Part II – Polysaccharides and Proteins

Unveiling the Ineffectiveness: Sox10’s Non-Participation in Ovarian Serous Carcinoma; Retrospective Clinicopathological Analysis from National Cancer Institute

Conclusion

Dr. Ebrahim’s in-depth research, excellence in oncology, and consistent contributions to cancer diagnostics and treatment strategies make her an exceptional contender for the “Best Researcher Award.” Her work’s translational impact on cancer care and her dedication to advancing scientific knowledge position her as a leader in oncologic pathology. With her outstanding record of research, publication, and recognition, Dr. Ebrahim is undoubtedly a deserving candidate for this prestigious honor.